Gene therapy in sickle cell and thalassaemia – where cutting-edge science meets clinical need

July 2024

What does the approval for human use of new gene editing techniques mean for patients?

Gene therapy in sickle cell and thalassaemia – where cutting-edge science meets clinical need

July 2024

This article reports on the development of gene therapy treatment for sickle cell and thalassaemia.

Also of interest

RCPath response to the UK NSC Consultation on screening of neonates and adults for thrombophilia
Published: April 2017
Published: April 2017
An audit of compliance with the BSH guideline on the management of mature T-cell and NK-cell lymphomas (excluding cutaneous T-cell lymphoma).docx
Published: June 2022
Published: June 2022
An audit of compliance with the standards for reporting and acting on critical results in haematology - high INR for patients who are on Warfarin
Published: July 2013
Published: July 2013
Part 1 Haematology Paper 1 - Past Papers
Published: November 2016
Published: November 2016
An audit of compliance with the British Society for Haematology guideline on the management of sickle cell disease in pregnancy.docx 1
Published: May 2022
Published: May 2022

More resources